Robeco Institutional Asset Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.55M | Sell |
59,705
-45,608
| -43% | -$2.48M | ﹤0.01% | 631 |
|
|
2026
Q1 | $6.61M | Sell |
105,313
-2,887,564
| -96% | -$231M | 0.01% | 502 |
|
|
2025
Q4 | $285M | Sell |
2,992,877
-125,991
| -4% | -$12.4M | 0.41% | 49 |
|
|
2025
Q3 | $304M | Sell |
3,118,868
-26,909
| -0.9% | -$2.79M | 0.44% | 44 |
|
|
2025
Q2 | $338M | Buy |
3,145,777
+756,199
| +32% | +$76.5M | 0.55% | 33 |
|
|
2025
Q1 | $241M | Buy |
2,389,578
+467,277
| +24% | +$47.1M | 0.47% | 48 |
|
|
2024
Q4 | $172M | Buy |
1,922,301
+224,280
| +13% | +$19.7M | 0.33% | 61 |
|
|
2024
Q3 | $142M | Buy |
1,698,021
+321,574
| +23% | +$25.3M | 0.28% | 78 |
|
|
2024
Q2 | $106M | Buy |
1,376,447
+674,979
| +96% | +$49.4M | 0.23% | 95 |
|
|
2024
Q1 | $48M | Buy |
701,468
+107,181
| +18% | +$6.89M | 0.1% | 195 |
|
|
2023
Q4 | $34.4M | Buy |
594,287
+128,586
| +28% | +$6.86M | 0.08% | 241 |
|
|
2023
Q3 | $24.6M | Buy |
465,701
+12,757
| +3% | +$669K | 0.07% | 283 |
|
|
2023
Q2 | $24.5M | Buy |
452,944
+313,590
| +225% | +$16.4M | 0.06% | 289 |
|
|
2023
Q1 | $6.97M | Buy |
139,354
+4,049
| +3% | +$191K | 0.02% | 505 |
|
|
2022
Q4 | $6.26M | Sell |
135,305
-1,088,604
| -89% | -$47.1M | 0.02% | 530 |
|
|
2022
Q3 | $47.4M | Buy |
1,223,909
+137,425
| +13% | +$5.51M | 0.15% | 143 |
|
|
2022
Q2 | $40.5M | Buy |
1,086,484
+53,779
| +5% | +$2.19M | 0.13% | 163 |
|
|
2022
Q1 | $45.7M | Buy |
1,032,705
+16,567
| +2% | +$718K | 0.11% | 207 |
|
|
2021
Q4 | $43.2M | Buy |
1,016,138
+376,019
| +59% | +$15.8M | 0.09% | 239 |
|
|
2021
Q3 | $27.8M | Buy |
640,119
+494,655
| +340% | +$21.9M | 0.06% | 303 |
|
|
2021
Q2 | $6.22M | Buy |
145,464
+37,617
| +35% | +$1.58M | 0.01% | 550 |
|
|
2021
Q1 | $4.17M | Buy |
107,847
+6,211
| +6% | +$235K | 0.01% | 583 |
|
|
2020
Q4 | $3.65M | Buy |
101,636
+10,164
| +11% | +$366K | 0.01% | 592 |
|
|
2020
Q3 | $3.5M | Sell |
91,472
-5,767
| -6% | -$222K | 0.01% | 562 |
|
|
2020
Q2 | $3.41M | Buy |
97,239
+3,789
| +4% | +$136K | 0.01% | 584 |
|
|
2020
Q1 | $3.05M | Hold |
93,450
| – | – | 0.01% | 620 |
|
|
2019
Q4 | $4.22M | Buy |
93,450
+24,217
| +35% | +$1.01M | 0.01% | 629 |
|
|
2019
Q3 | $2.82M | Buy |
69,233
+15,385
| +29% | +$652K | 0.01% | 671 |
|
|
2019
Q2 | $2.31M | Sell |
53,848
-113,077
| -68% | -$4.35M | 0.01% | 685 |
|
|
2019
Q1 | $6.41M | Buy |
166,925
+46,280
| +38% | +$1.77M | 0.02% | 549 |
|
|
2018
Q4 | $4.26M | Buy |
120,645
+17,799
| +17% | +$646K | 0.02% | 565 |
|
|
2018
Q3 | $3.96M | Buy |
102,846
+18,241
| +22% | +$637K | 0.02% | 592 |
|
|
2018
Q2 | $2.77M | Sell |
84,605
-18,342
| -18% | -$553K | 0.01% | 612 |
|
|
2018
Q1 | $2.81M | Buy |
102,947
+10,801
| +12% | +$294K | 0.01% | 615 |
|
|
2017
Q4 | $2.28M | Sell |
92,146
-19,831
| -18% | -$547K | 0.01% | 600 |
|
|
2017
Q3 | $3.27M | Sell |
111,977
-1,130
| -1% | -$31.2K | 0.02% | 510 |
|
|
2017
Q2 | $3.13M | Sell |
113,107
-18,798
| -14% | -$499K | 0.02% | 510 |
|
|
2017
Q1 | $3.28M | Buy |
131,905
+67,876
| +106% | +$1.65M | 0.02% | 493 |
|
|
2016
Q4 | $1.39M | Sell |
64,029
-43,114
| -40% | -$941K | 0.01% | 553 |
|
|
2016
Q3 | $2.55M | Buy |
107,143
+4,065
| +4% | +$97K | 0.02% | 476 |
|
|
2016
Q2 | $2.41M | Buy |
103,078
+5,191
| +5% | +$112K | 0.02% | 488 |
|
|
2016
Q1 | $1.84M | Buy |
97,887
+7,763
| +9% | +$136K | 0.01% | 516 |
|
|
2015
Q4 | $1.66M | Sell |
90,124
-4,967
| -5% | -$89K | 0.01% | 525 |
|
|
2015
Q3 | $1.56M | Buy |
95,091
+10,019
| +12% | +$171K | 0.01% | 503 |
|
|
2015
Q2 | $1.5M | Buy |
85,072
+4,967
| +6% | +$88.8K | 0.01% | 538 |
|
|
2015
Q1 | $1.42M | Sell |
80,105
-118,300
| -60% | -$1.87M | 0.01% | 523 |
|
|
2014
Q4 | $2.63M | Sell |
198,405
-62,516
| -24% | -$799K | 0.02% | 427 |
|
|
2014
Q3 | $3.08M | Sell |
260,921
-39,381
| -13% | -$496K | 0.02% | 388 |
|
|
2014
Q2 | $3.83M | Buy |
300,302
+88,102
| +42% | +$1.15M | 0.03% | 346 |
|
|
2014
Q1 | $2.87M | Hold |
212,200
| – | – | 0.02% | 369 |
|
|
2013
Q4 | $2.55M | Buy |
212,200
+9,552
| +5% | +$113K | 0.02% | 343 |
|
|
2013
Q3 | $2.38M | Buy |
202,648
+94,968
| +88% | +$1.03M | 0.02% | 358 |
|
|
2013
Q2 | $998K | Buy |
+107,680
| New | +$913K | 0.01% | 437 |
|
Other funds holding BSX
Robeco Institutional Asset Management's BSX Position: Q2 2026 in Review
Robeco Institutional Asset Management reduced its Boston Scientific (BSX) stake by 43% in Q2 2026, selling an estimated $2.48M and leaving 59,705 shares worth $2.55M. The position accounts for ﹤0.01% of the portfolio, ranked #631.
Robeco Institutional Asset Management first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $338M in Q2 2025. 770 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Robeco Institutional Asset Management held 59,705 shares of Boston Scientific worth $2.55M as of Q2 2026.
- Robeco Institutional Asset Management sold 45,608 Boston Scientific shares in Q2 2026, an estimated $2.48M.
- Boston Scientific made up ﹤0.01% of Robeco Institutional Asset Management's portfolio in Q2 2026, its #631 holding.
- Robeco Institutional Asset Management first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
- Robeco Institutional Asset Management's Boston Scientific position peaked at $338M in Q2 2025.
- 770 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Robeco Institutional Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.